Krishna Institute of Medical Sciences Ltd

Krishna Institute of Medical Sciences Ltd (KIMS) has experienced a notable shift in its valuation parameters, moving from a very expensive to an expensive rating. This change, reflected in key metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios, signals a subtle recalibration in the stock’s price attractiveness amid a challenging hospital sector landscape. Investors should weigh these valuation dynamics against the company’s operational performance and peer comparisons to assess its market positioning.

Krishna Institute of Medical Sciences Ltd (KIMS) commenced trading today with a significant gap down, opening at a price 11.88% lower than its previous close. This weak start reflects heightened market concerns, resulting in notable intraday volatility and a cautious trading environment for the hospital sector stock.

Krishna Institute of Medical Sciences Ltd (KIMS) has seen a notable shift in its valuation parameters, moving from an already expensive rating to a very expensive classification. With a price-to-earnings (P/E) ratio soaring to 100.45 and a price-to-book value (P/BV) of 12.93, investors are now faced with a more challenging price attractiveness scenario compared to both historical averages and peer benchmarks within the hospital sector.

Krishna Institute of Medical Sciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 11 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 February 2026, providing investors with the latest insights into its performance and outlook.

Krishna Institute of Medical Sciences Ltd (KIMS) has seen its investment rating upgraded from Strong Sell to Sell as of 11 February 2026, reflecting a nuanced shift in its financial and technical outlook. Despite persistent challenges in profitability and financial health, the stock’s recent price performance and technical indicators have improved sufficiently to warrant a less severe rating, though caution remains advised.

Krishna Institute of Medical Sciences Ltd (KIMS), a key player in the hospital sector, has experienced a notable shift in price momentum and technical indicators, reflecting a complex market sentiment. Despite a strong day change of 8.65%, the stock’s technical parameters reveal a nuanced picture with mixed signals from MACD, RSI, moving averages, and other trend indicators, prompting a reassessment of its near-term outlook.

Krishna Institute of Medical Sciences Ltd recorded a robust intraday performance on 9 Feb 2026, surging to a day’s high of Rs 638, marking a 7.24% increase. This strong rebound follows three consecutive days of decline, signalling a notable shift in trading momentum within the hospital sector.

Krishna Institute of Medical Sciences Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 06 February 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock’s current position as of 07 February 2026, providing investors with the most up-to-date analysis.

Krishna Institute of Medical Sciences Ltd. (KIMS), one of India's leading hospital chains with a market capitalisation of ₹27,714 crores, reported a sharp 39.80% year-on-year decline in consolidated net profit to ₹53.40 crores for Q3 FY26 (October-December 2025), despite posting record quarterly revenues. The stock closed at ₹683.60 on February 13, down 2.18% for the day, as investors digested the concerning profitability trends that have emerged over the past three quarters.

Krishna Institute of Medical Sciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 09 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 27 January 2026, providing investors with the latest insights into its performance and outlook.

Krishna Institute of Medical Sciences Ltd (KIMS) has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The stock’s recent price action, combined with deteriorating moving averages and mixed oscillator signals, suggests mounting pressure on the hospital sector player amid broader market volatility.

Krishna Institute of Medical Sciences Ltd (KIMS) has experienced a nuanced shift in its technical landscape, with key indicators signalling a transition from bearish to mildly bearish momentum. Despite a modest day gain of 1.34%, the stock’s technical parameters present a complex picture that investors should carefully analyse amid evolving market conditions.

Krishna Institute of Medical Sciences Ltd (KIMS) has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to a more pronounced bearish trend. This change coincides with a downgrade in its Mojo Grade from Hold to Sell as of 09 Dec 2025, reflecting growing concerns over the stock’s near-term performance despite its solid long-term returns.

Krishna Institute of Medical Sciences Ltd (KIMS), a key player in the hospital sector, has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish indicators. Despite a recent upgrade in price, the stock’s overall technical outlook remains cautious, with several indicators signalling a mild bearish trend amid pockets of strength.

Krishna Institute of Medical Sciences Ltd (KIMS) has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. Following a downgrade from Hold to Sell on 9 December 2025, the hospital sector stock has seen its price decline by 3.62% on 7 January 2026, reflecting growing investor caution amid mixed technical signals and a challenging market backdrop.

Krishna Institute of Medical Sciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 09 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 January 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook.

Krishna Institute of Medical Sciences Ltd (KIMS) has experienced a notable shift in its technical momentum, with recent indicators signalling a transition from bearish to mildly bearish trends. Despite a positive day change of 2.68%, the stock’s technical landscape presents a complex picture, with mixed signals from MACD, RSI, Bollinger Bands, and moving averages, reflecting cautious investor sentiment in the hospital sector.